Merck to Hold Third-Quarter 2020 Sales and Earnings Conference Call on October 27 Pharmaceutical Investing
Public coverage of AbbVie's SKYRIZI® for the treatment of Moderate to Severe Plaque Psoriasis is now available across additional jurisdictions Biotech Investing
Mydecine Innovations Group Announces The Official Mindleap Health Mobile App Launch in IOS and Android Stores Today Psychedelics Investing
Gilead Sciences Presents Data From HIV Research and Development Programs at HIV Glasgow 2020 Biotech Investing
CStone, Pfizer Enter into Strategic Collaboration to Address Oncological Needs in China Pharmaceutical Investing
Perimeter Medical Imaging AI to Present at the Virtual Gravitas Healthcare Investor Day Medical Device Investing
Algernon Announces Enrollment of 100 Patients in Multinational 2b/3 Human Study of Ifenprodil for Treatment of COVID-19 Biotech Investing
BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer
Marvel Biosciences Advances MB-204 Toward First-in Human Testing, Selects CMAX as Phase I Clinical Trial Site
